2021

ACTG announces publication of REPRIEVE sub-study in JAMA Network Open, providing insights into cardiovascular disease risk among people living with HIV

Los Angeles, Calif. – The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced that findings from a sub-study of REPRIEVE (A5332/A5332s, an international clinical trial studying heart disease prevention in people living with HIV) have been published in the Journal of the American Medical Association Network Open (JAMA Network Open).…

Major UKRI – Versus Arthritis investment funds transformative pain research

A £14 million investment will help massively scale up research into chronic pain to improve outcomes for the many people living with painful and debilitating conditions, such as lower back pain. This is a joint and equal investment from UKRI and the charity Versus Arthritis. For UKRI, the initiative is led by the Medical Research…

Juul Settles N.C. Vaping Case, Agrees to Pay $40 Million

Mr. Tobias said he was not surprised that Juul did not admit to wrongdoing. “That almost always happens in these kinds of settlements — that’s a standard clause,” he said. Juul has not begun other serious settlement talks, however, because none of the other 2,600 lawsuits against the company have been scheduled to begin during…

Three Studies, One Result: Coronavirus Vaccines Point the Way Out of the Pandemic

Three scientific studies released on Monday offered fresh evidence that widely used vaccines will continue to protect people against the coronavirus for long periods, possibly for years, and can be adapted to fortify the immune system still further if needed. Most people immunized with the mRNA vaccines may not need boosters, one study found, so…

Mixing Pfizer, AstraZeneca Vaccines Gives Strong Covid Protection, Study Finds

Early results from a British vaccine study suggest that mixing different brands of vaccines can provoke a protective immune response against Covid-19. In the trial, volunteers produced high levels of antibodies and immune cells after getting one dose of the Pfizer-BioNTech vaccine and one dose of the AstraZeneca-Oxford shot. Administering the vaccines in either order…